LEGAL & COMPLIANCE
Practical Engagement
MDMA works with our members on best practices, benchmarking, and latest compliance trends. In addition, we’re the only national MedTech association fighting for innovators IP rights.
Compliance Resources
We bring together member company compliance professionals and provide resources for establishing or enhancing compliance programs at companies of all sizes
Protecting IP
MDMA has led the fight against efforts to weaken intellectual property protections. We believe strong IP allows innovation to flourish and improves patient outcomes
Legal Trends
MDMA provides a forum for members to discuss legal trends and hear from experts on issues including antitrust developments, product liability, data privacy and security, and other rapidly-evolving topics
WHY compliance MATTERS
Our member companies operate in a complex regulatory and legal environment in the U.S. and internationally. Understanding how these frameworks apply to your business, and what policies and procedures your company should implement or update to ensure compliance, is essential to protect your business.
At its most basic level, the purpose of an effective compliance program is to reduce the risk of penalties, which can be serious. But having an effective compliance program is about more than just avoiding legal trouble. By prioritizing ethics and integrity, companies can foster employee morale and the trust of health care providers, patients and the public. Maintaining a high ethical standard across our industry protects innovative companies from the anticompetitive effects of collusion and corruption.
MDMA helps members stay up to date on important developments affecting their compliance programs and provides a forum to benchmark with peers on best practices.
Click here for more compliance news and information.
“MDMA’s partnership has been instrumental in helping us tackle the complexities of the medical technology industry. Their advocacy, educational support, and collaborative environment, enriched by input from other members in various working groups, have enabled us to confidently stay abreast of regulatory changes.”
Ryan Hulslander | Vice President, General Counsel, Cochlear